Company intelligence / Profile preview
CureZome
Seoul, South Koreacurezonepharma.in ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CureZome is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and drug delivery systems. The company leverages its proprietary platform to isolate and engineer exosomes for the treatment of various conditions, including liver diseases, inflammatory disorders, and oncology. By utilizing the natural communication and transport capabilities of extracellular vesicles, CureZome aims to deliver therapeutic payloads with high specificity and reduced immunogenicity. The company's pipeline is currently in the pre-clinical stage, focusing on optimizing exosome cargo and targeting mechanisms.
- Therapeutic areas
- OncologyImmunologyGastroenterology
- Modalities
- Exosome-based therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on CureZome.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CureZome.